Stephan Rosenkranz
-
- Cardiovascular Function and Risk Factors 58
- Heart Failure Treatment and Management 54
- Cardiovascular Issues in Pregnancy 27
- Cardiac Valve Diseases and Treatments 15
- Pulmonary and Respiratory Medicine top 0.2%
- Pulmonary Hypertension Research and Treatments 156
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 15
- Internal Medicine top 1%
- Venous Thromboembolism Diagnosis and Management 13
- Genetics top 1%
- Hepatology top 2%
-
- Cardiovascular and exercise physiology 10
- Co-authors
- Michael BöhmMarius M. HoeperHossein Ardeschir GhofraniEkkehard GrünigJean‐Luc VachiéryJ. Simon R. GibbsTeresa De MarcoAnton Vonk Noordegraaf
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Stephan Rosenkranz
248 papers receiving 9.9k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Cardiology and Cardiovascular Medicine 5.6k
- Pulmonary and Respiratory Medicine 5.2k
- Internal Medicine 374
- Genetics 692
- Hepatology 385
Countries citing papers authored by Stephan Rosenkranz
This map shows the geographic impact of Stephan Rosenkranz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephan Rosenkranz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephan Rosenkranz more than expected).
Fields of papers citing papers by Stephan Rosenkranz
This network shows the impact of papers produced by Stephan Rosenkranz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephan Rosenkranz. The network helps show where Stephan Rosenkranz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Stephan Rosenkranz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 13 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 3 | |
| 10 | 2023 | 20 | |
| 11 | Interventional therapies for pulmonary embolismbreakdown → | 2023 | 53 |
| 12 | 2023 | 48 | |
| 13 | 2022 | 10 | |
| 14 | 2022 | 7 | |
| 15 | 2021 | 105 | |
| 16 | 2021 | 16 | |
| 17 | 2020 | 118 | |
| 18 | 2019 | 17 | |
| 19 | 2012 | 161 | |
| 20 | 2008 | 53 |
About Stephan Rosenkranz
Stephan Rosenkranz is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Internal Medicine, having authored 267 papers that have together received 10.0k indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (156 papers), Cardiovascular Function and Risk Factors (58 papers), Heart Failure Treatment and Management (54 papers), Cardiovascular Issues in Pregnancy (27 papers), Cardiac Valve Diseases and Treatments (15 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (15 papers), Venous Thromboembolism Diagnosis and Management (13 papers) and Cardiovascular and exercise physiology (10 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (5.6k citations), Pulmonary and Respiratory Medicine (5.2k citations) and Internal Medicine (374 citations). Stephan Rosenkranz has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Michael Böhm, Marius M. Hoeper, Hossein Ardeschir Ghofrani, Ekkehard Grünig, Jean‐Luc Vachiéry, J. Simon R. Gibbs, Teresa De Marco, Anton Vonk Noordegraaf, Andrius Kazlauskas and Marius Vantler.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.